
Franklin Resources’s Vanda Pharmaceuticals VNDA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-38,926
| Closed | -$179K | – | 3123 |
|
2025
Q1 | $179K | Buy |
38,926
+19,146
| +97% | +$87.9K | ﹤0.01% | 2706 |
|
2024
Q4 | $94.7K | Sell |
19,780
-35,446
| -64% | -$170K | ﹤0.01% | 2749 |
|
2024
Q3 | $266K | Buy |
55,226
+4,449
| +9% | +$21.4K | ﹤0.01% | 2527 |
|
2024
Q2 | $287K | Buy |
50,777
+31,845
| +168% | +$180K | ﹤0.01% | 2441 |
|
2024
Q1 | $77.8K | Buy |
18,932
+791
| +4% | +$3.25K | ﹤0.01% | 2724 |
|
2023
Q4 | $76.6K | Sell |
18,141
-42,751
| -70% | -$180K | ﹤0.01% | 2487 |
|
2023
Q3 | $263K | Sell |
60,892
-137,431
| -69% | -$594K | ﹤0.01% | 2200 |
|
2023
Q2 | $1.31M | Buy |
198,323
+35,572
| +22% | +$234K | ﹤0.01% | 1551 |
|
2023
Q1 | $1.11M | Buy |
162,751
+840
| +0.5% | +$5.7K | ﹤0.01% | 1477 |
|
2022
Q4 | $1.2M | Buy |
161,911
+519
| +0.3% | +$3.84K | ﹤0.01% | 1477 |
|
2022
Q3 | $1.59M | Buy |
161,392
+80,777
| +100% | +$798K | ﹤0.01% | 1407 |
|
2022
Q2 | $880K | Buy |
80,615
+48,864
| +154% | +$533K | ﹤0.01% | 1563 |
|
2022
Q1 | $359K | Hold |
31,751
| – | – | ﹤0.01% | 1946 |
|
2021
Q4 | $498K | Sell |
31,751
-146
| -0.5% | -$2.29K | ﹤0.01% | 1905 |
|
2021
Q3 | $546K | Buy |
+31,897
| New | +$546K | ﹤0.01% | 1849 |
|